COVID-19 Research Paper Volume 14, Issue 18 pp 7193—7205
Humoral immunoresponse elicited against an adenoviral-based SARS-CoV-2 coronavirus vaccine in elderly patients
Figure 4. Anti-SARS-CoV-2 humoral immune responses in different age subgroups. Serum IgG anti-RBD of the SARS-CoV-2 were determined at several times post Gam-COVID-Vac in individuals classified into the following age subgroups: 70-74, 75-79, 80-84 and 85-96 years old. Horizontal red lines represent the median.